Active surveillance for favorable-risk prostate cancer: who, how and why?

被引：0
|
作者：
Laurence Klotz
机构：
[1] L Klotz is Chief of Urology at the Sunnybrook Health Sciences Centre,
[2] and Professor of Surgery at the University of Toronto,undefined
[3] Toronto,undefined
[4] ON,undefined
[5] Canada.,undefined
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Active surveillance for favorable-risk prostate cancer has become increasingly popular in populations in which prostate cancer screening is widespread because of evidence that screening results in the detection of disease that is not clinically significant in many patients. This Review discusses the results of active surveillance, the criteria for patient selection and the appropriate thresholds for intervention.
引用
收藏
页码：692 / 698
页数：6
相关论文
共 50 条
  • [1] Active surveillance for favorable-risk prostate cancer: who, how and why?
    Klotz, Laurence
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (12): : 692 - 698
  • [2] Active surveillance for favorable-risk prostate cancer: What are the results and how safe is it?
    Laurence Klotz
    [J]. Current Urology Reports, 2007, 8 (5) : 341 - 344
  • [3] Thoughts on Criteria for Active Surveillance of Favorable-risk Prostate Cancer
    Gettman, Matthew T.
    [J]. EUROPEAN UROLOGY, 2016, 70 (06) : 961 - 962
  • [4] Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
    Lawrentschuk, Nathan
    Klotz, Laurence
    [J]. KOREAN JOURNAL OF UROLOGY, 2010, 51 (10) : 665 - 670
  • [5] Incidence of Reclassification in Patients Undergoing Active Surveillance for Favorable-Risk Prostate Cancer
    Kim, J.
    Davis, J. W.
    Ward, J.
    Wang, X.
    Pettaway, C.
    Pisters, L.
    Matin, S.
    Kuban, D.
    Frank, S. J.
    Lee, A. K.
    Prokhorova, I. N.
    Brown, V. T.
    Logothetis, C. J.
    Troncoso, P.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 204A - 204A
  • [6] Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer
    Kenfield S.A.
    Chang S.T.
    Chan J.M.
    [J]. Current Treatment Options in Oncology, 2007, 8 (3) : 173 - 196
  • [7] Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer
    Thomsen, Frederik B.
    Roder, M. Andreas
    Jakobsen, Henrik
    Langkilde, Niels Christian
    Borre, Michael
    Jakobsen, Erik B.
    Frey, Anders
    Lund, Lars
    Lunden, Dagmar
    Dah, Claus
    Brasso, Klaus
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (04) : E814 - E821
  • [8] ACTIVE SURVEILLANCE FOR FAVORABLE-RISK PROSTATE CANCER: AN UPDATE OF THE UNIVERSITY OF MIAMI PROGRAM
    Soloway, Mark S.
    Eldefrawy, Ahmed
    Manoharan, Murugesan
    Iremashvili, Viacheslav
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E273 - E274
  • [9] Active surveillance versus radical treatment for favorable-risk localized prostate cancer
    Klotz L.
    [J]. Current Treatment Options in Oncology, 2006, 7 (5) : 355 - 362
  • [10] Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer
    Radhakrishnan, Archana
    Wallner, Lauren P.
    Skolarus, Ted A.
    George, Arvin K.
    Rosenberg, Bradley H.
    Abrahamse, Paul
    Hawley, Sarah T.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (03): : 600 - 608
12345